Capital Fund Management (CFM)
AMPH icon

Capital Fund Management (CFM)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Capital Fund Management (CFM)’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40,570
Closed -$931K – 2420
2025
Q2 		$931K Buy
+40,570
New +$1.01M ﹤0.01% 2024
2022
Q3 		– Sell
-13,955
Closed -$485K – 1398
2022
Q2 		$485K Buy
+13,955
New +$498K ﹤0.01% 1256
2016
Q1 		– Sell
-18,974
Closed -$270K – 1493
2015
Q4 		$270K Buy
+18,974
New +$251K ﹤0.01% 1354

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Capital Fund Management (CFM)'s AMPH Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2025, closing a stake of 40,570 shares — an estimated $931K sold.

Capital Fund Management (CFM) first reported a position in AMPH in Q4 2015 and held it in 3 quarters. The position peaked at $931K in Q2 2025. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Amphastar Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 40,570 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $931K.
  • Capital Fund Management (CFM) first reported a position in Amphastar Pharmaceuticals in Q4 2015 and held it in 3 quarters.
  • Capital Fund Management (CFM)'s Amphastar Pharmaceuticals position peaked at $931K in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.